No Data
With 45% Institutional Ownership, BeiGene, Ltd. (NASDAQ:BGNE) Is a Favorite Amongst the Big Guns
US stock movement | BEIGENE pre-market up about 1.6%, plans to change its US stock code, reaffirms commitment to providing innovative cancer drugs.
On December 24, Glonghui reported that BEIGENE (BGNE.US) increased by about 1.6% pre-market, reaching $180.53. In news, BEIGENE announced that to reflect the company's steadfast commitment to providing innovative cancer drugs globally, the stock code for its American Depositary Shares listed on Nasdaq will change from "BGNE" to "ONC," effective January 2, 2025. (Glonghui)
CCTV interprets a more proactive fiscal policy: next year's fiscal funding will be allocated earlier, faster, and in greater amounts.
Next year, a more proactive fiscal policy will be implemented. What measures will the Ministry of Finance take? Where will the fiscal funds be focused? What impact will this have on our lives?
BEIGENE (06160.HK) Nasdaq stock code changed to "ONC".
BEIGENE (06160.HK)(BGNE.US) announced that in order to reflect the company's firm commitment to providing innovative oncology drugs globally, the stock code for the American depositary shares traded on Nasdaq will change from "BGNE" to "ONC," effective January 2, 2025.
BeiGene Ltd Updates Nasdaq Ticker Symbol
BeiGene to Rebrand as BeOne Medicines With Oncology-Focused New Nasdaq Ticker "ONC"